SMO mutations confer poor prognosis in malignant pleural mesothelioma
TRANSLATIONAL LUNG CANCER RESEARCH
Authors: Signorelli, Diego; Proto, Claudia; Botta, Laura; Trama, Annalisa; Tiseo, Marcello; Pasello, Giulia; Lo Russo, Giuseppe; Fabbri, Alessandra; Imbimbo, Martina; Busico, Adele; Prelaj, Arsela; Ferrara, Roberto; Galli, Giulia; De Toma, Alessandro; Tamborini, Elena; Pastorino, Ugo; de Braud, Filippo; Gatta, Gemma; Garassino, Marina Chiara; Ganzinelli, Monica
Abstract
Background: Malignant pleural mesothelioma (MPM) is an aggressive tumor but approximately 12% of patients survive more than 3 years. The biological differences underlying better outcomes are not known. Several targeted agents and immunotherapy have been ineffective. Hedgehog (Hh) is one emerging pathway. We compared the biological profiles of patients with different survival, investigating the most frequently altered genes, including the Hh pathway. Methods: We analyzed 56 MPM. A 36-month overall survival (OS) cut-off divided patients into 32 normo (NS) and 24 long (LS) survivors. We used next generation sequencing to test 21 genes, immunohistochemistry to evaluate SMO expression. Mutation differences between NS and LS and their associations with clinical features were analysed by Fisher's test, OS with the Kaplan-Meier method and its association with mutations by univariate and multivariate Cox proportional hazard models. Results: Clinical features were similar in both groups. Eighteen out of 56 patients (32%) were wild-type for the genes analysed. At least five had mutations in BAP1, NF2, TP53, SMO and PTCH1 with no significant differences between the groups except for SMO. SMO, a member of the Hh pathway, was mutated only in NS (15.6%) and only SMO mutations were significantly associated with poor prognosis at univariate (HR=4.36, 95% CI: 2.32-8.18, P<0.0001) and multivariate (HR=9.2, 95% CI: 3.0-28.4, P=0.0001) analysis. All SMO mutated patients expressed high protein levels. Conclusions: SMO mutations were clearly associated with worse prognosis. SMO may be a therapeutic target but this needs to be confirmed in a prospective trial.
Baby fish working out: an epigenetic source of adaptive variation in the cichlid jaw
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Authors: Hu, Yinan; Albertson, R. Craig
Abstract
Understanding the developmental processes that underlie the production of adaptive variation (i.e. the 'arrival of the fittest') is a major goal of evolutionary biology. While most evo-devo studies focus on the genetic underpinnings of adaptive phenotypic variation, factors beyond changes in nucleotide sequence can also play a major role in shaping developmental outcomes. Here, we document a vigorous but enigmatic gaping behaviour during the early development of Lake Malawi cichlid larvae. The onset of the behaviour precedes the formation of bone, and we predicted that it might influence craniofacial shape by affecting the mechanical environment in which bone develops. Consistent with this, we found that both natural variation and experimental manipulation of this behaviour induced differential skeletal development that foreshadows adaptive variation in adult trophic morphology. In fact, the magnitude of difference in skeletal morphology induced by these simple shifts in behaviour was similar to those predicted to be caused by genetic factors. Finally, we demonstrate that this mechanical-load-induced shift in skeletal development is associated with differences in ptch1 expression, a gene previously implicated in mediating between-species differences in skeletal shape. Our results underscore the complexity of development, and the importance of epigenetic (sensu Waddington) mechanisms in determining adaptive phenotypic variation.